Cargando…

4′-O-substitutions determine selectivity of aminoglycoside antibiotics

Clinical use of 2-deoxystreptamine aminoglycoside antibiotics, which target the bacterial ribosome, is compromised by adverse effects related to limited drug selectivity. Here we present a series of 4′,6′-O-acetal and 4′-O-ether modifications on glucopyranosyl ring I of aminoglycosides. Chemical mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Perez-Fernandez, Déborah, Shcherbakov, Dmitri, Matt, Tanja, Leong, Ng Chyan, Kudyba, Iwona, Duscha, Stefan, Boukari, Heithem, Patak, Rashmi, Dubbaka, Srinivas Reddy, Lang, Kathrin, Meyer, Martin, Akbergenov, Rashid, Freihofer, Pietro, Vaddi, Swapna, Thommes, Pia, Ramakrishnan, V., Vasella, Andrea, Böttger, Erik C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Pub. Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942853/
https://www.ncbi.nlm.nih.gov/pubmed/24473108
http://dx.doi.org/10.1038/ncomms4112
Descripción
Sumario:Clinical use of 2-deoxystreptamine aminoglycoside antibiotics, which target the bacterial ribosome, is compromised by adverse effects related to limited drug selectivity. Here we present a series of 4′,6′-O-acetal and 4′-O-ether modifications on glucopyranosyl ring I of aminoglycosides. Chemical modifications were guided by measuring interactions between the compounds synthesized and ribosomes harbouring single point mutations in the drug-binding site, resulting in aminoglycosides that interact poorly with the drug-binding pocket of eukaryotic mitochondrial or cytosolic ribosomes. Yet, these compounds largely retain their inhibitory activity for bacterial ribosomes and show antibacterial activity. Our data indicate that 4′-O-substituted aminoglycosides possess increased selectivity towards bacterial ribosomes and little activity for any of the human drug-binding pockets.